Compare Global X Data Center & Digital Infra ETF (DTCR) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance

Global X Data Center & Digital Infra ETFTrade

Nuvation Bio Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Global X Data Center & Digital Infra ETF vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Global X Data Center & Digital Infra ETF trades at $27.65 (market cap $2.04B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.74B). The key difference: Global X Data Center & Digital Infra ETF is the larger of the two by market cap, and Global X Data Center & Digital Infra ETF is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Data Center & Digital Infra ETF for 15 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.

	DTCR	NUVB
Market Cap	$2.04B	$1.74B
Volume	899,532	9,289,619
Sector	Sector/Thematic	Health
52-Week High	$32.46	$9.54
52-Week Low	$19.73	$3.41
Typical Hold Time	15 Days	0 Days
Enterprise Value	—	$1.33B

View details →View details →

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DTCR

68% Buy32% Sell

Avg holding period · 15 Days

NUVB

100% Buy0% Sell

Avg holding period · 0 Days

Top news

Latest headlines on both assets

DTCR

Data center builders IREN, TeraWulf, and Core Scientific fall sharply due to rising borrowing costs.24/7 Wall Street · 2 days agoBearish Applied Digital rises 3% on Finland power deal opening 1 GW data center capacity ahead of earnings.24/7 Wall Street · 3 days agoBullish View details →

NUVB

View details →

About Global X Data Center & Digital Infra ETF

Global X Data Center & Digital Infrastructure ETF seeks exposure to companies involved in data centers and digital infrastructure. Its holdings span areas such as digital infrastructure, networking, and related real estate.

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.